Dipiro's Pharmacotherapy, now in its 12th edition, is a renowned textbook that has been a cornerstone of pharmacotherapy education for decades. This esteemed resource has been widely adopted by pharmacy schools, healthcare professionals, and students worldwide, providing a thorough understanding of the principles and practices of pharmacotherapy. In this article, we will explore the key features, updates, and significance of the 12th edition of Dipiro's Pharmacotherapy.
The 11th edition was published before COVID-19 was declared a pandemic. A student studying solely from the 11th edition would have zero knowledge of antiviral management of SARS-CoV-2, vaccine principles (mRNA technology), or post-COVID syndrome. This alone justifies the upgrade for infectious disease specialists. dipiro pharmacotherapy 12th edition
1st line: Metformin (unless CKD G4+). Add-on based on comorbidities: Dipiro's Pharmacotherapy, now in its 12th edition, is
✅